Literature DB >> 789240

Nonspecific resistance against infection with Salmonella typhi and Salmonella typhimurium induced in mice by cord factor (trehalose-6,6'-dimycolate) and its analogues.

E Yarkoni, A Bekierkunst.   

Abstract

Mice pretreated intraperitoneally with trehalose-6,6'-dimycolate (cord factor) were protected against an intraperitoneal challenge with Salmonella typhi strain Ty2 or Salmonella typhimurium strain SR 11. The nonspecific resistance to S. typhi and S. typhimurium was still detectable 7 and 14 days, respectively, after administration of cord factor. The effect of cord factor was local. Synthetic analogues of cord factor--trehalose-6,6'-dipalmitate and trehalose monopalmitate--also induced nonspecific resistance to the above virulent bacteria. The results are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 789240      PMCID: PMC415503          DOI: 10.1128/iai.14.5.1125-1129.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Cord factor and related trehalose esters.

Authors:  E Lederer
Journal:  Chem Phys Lipids       Date:  1976-03       Impact factor: 3.329

2.  Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.

Authors:  B Zbar; E Ribi; T Meyer; I Azuma; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1974-05       Impact factor: 13.506

3.  Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin.

Authors:  B Zbar; I D Bernstein; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1971-04       Impact factor: 13.506

4.  Protective effects of delipidated mycobacterial cells and purified cell walls against Ehrlich carcinoma and a syngeneic lymphoid leukemia in mice.

Authors:  L Chedid; A Lamensans; F Parant; M Parant; A Adam; J F Petit; E Lederer
Journal:  Cancer Res       Date:  1973-09       Impact factor: 12.701

5.  Supression of growth of Ehrlich ascites tumor cells in mice pretreated with synthetic analogs of trehalose-6,6-dimycolate (cord factor).

Authors:  E Yarkoni; A Bekierkunst; J Asselineau; R Toubiana; M J Toubiana; E Lederer
Journal:  J Natl Cancer Inst       Date:  1973-08       Impact factor: 13.506

6.  [Synthesis of cord factor analogs. II. Preparation of trehalose 6,6-dipalmitate by transesterification].

Authors:  R Toubiana; M J Toubiana
Journal:  Biochimie       Date:  1973-05       Impact factor: 4.079

7.  Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6'-dimycolate).

Authors:  A Bekierkunst
Journal:  Int J Cancer       Date:  1975-09-15       Impact factor: 7.396

8.  [Cord factor and its analogs. III. Synthesis of cord factor (6,6'-di-O-mycoloyl-alpha, alpha-trehalose) and 6,6'-di-O-palmitoyl-alpha, alpha-trehalose].

Authors:  R Toubiana; B C Das; J Defaye; B Mompon; M J Toubiana
Journal:  Carbohydr Res       Date:  1975-11       Impact factor: 2.104

9.  Suppression of growth of Ehrlich ascites tumor cells in mice by trehalose-6,6'-dimycolate (cord factor) and BCG.

Authors:  E Yarkoni; L Wang; A Bekierkunst
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

10.  Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression.

Authors:  A Bekierkunst; L Wang; R Toubiana; E Lederer
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

View more
  12 in total

1.  Enhanced resistance against encephalomyocarditis virus infection in mice, induced by a nonviable Mycobacterium tuberculosis oil-droplet vaccine.

Authors:  D L Lodmell; L C Ewalt
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

2.  Granuloma formation in lungs of mice after intravenous administration of emulsified trehalose-6,6'-dimycolate (cord factor): reaction intensity depends on size distribution of the oil droplets.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

3.  Induction of enhanced resistance against encephalomyocarditis virus infection of mice by nonviable Mycobacterium tuberculosis: mechanisms of protection.

Authors:  D L Lodmell; L C Ewalt
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

4.  Nonspecific immunostimulant activities of synthetic trehalose-6,6'-diesters (lower homologs of cord factor).

Authors:  M Parant; F Audibert; F Parant; L Chedid; E Soler; J Polonsky; E Lederer
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

5.  Failure of trehalose-6,6'-dimycolate (P3 or cord factor) to enhance endotoxin lethality in mice.

Authors:  E Yarkoni; M S Meltzer; H J Rapp
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

6.  Trehalose dimycolate enhances resistance to infection in neutropenic animals.

Authors:  G S Madonna; G D Ledney; T B Elliott; I Brook; J T Ulrich; K R Myers; M L Patchen; R I Walker
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

7.  Proliferative responses of central and peripheral rat lymphocytes elicited by cord factor (trehalose 6,6'-dimycolate).

Authors:  F Kierszenbaum; D R Walz
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

8.  Stimulation of macrophages by cord factor and by heat-killed and living BCG.

Authors:  E Yarkoni; L Wang; A Bekierkunst
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

9.  Macrophage activation by cord factor (trehalose 6,6'-dimycolate): enhanced association with and intracellular killing of Trypanosoma cruzi.

Authors:  F Kierszenbaum; A Zenian; J J Wirth
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

10.  Mycobacterial trehalose dimycolate reprograms macrophage global gene expression and activates matrix metalloproteinases.

Authors:  Kaori Sakamoto; Mi Jeong Kim; Elizabeth R Rhoades; Rachel E Allavena; Sabine Ehrt; Helen C Wainwright; David G Russell; Kyle H Rohde
Journal:  Infect Immun       Date:  2012-12-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.